Lataa...
Potential of Biosimilars to Increase Access to Biologics: Considerations for Advanced Practice Providers in Oncology
Biosimilars are biologic products that are highly similar, but not identical, to a licensed reference (or "originator") biologic product. These agents have the potential to provide efficiencies and improve access to treatment for patients. Biosimilars are currently available for use in cli...
Tallennettuna:
| Julkaisussa: | J Adv Pract Oncol |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Harborside Press
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6570521/ https://ncbi.nlm.nih.gov/pubmed/31249718 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|